#Radical #vaginal #trachelectomy - Longterm #oncologic & #fertility outcomes in women with early #CervicalCancer
📃@ bit.ly/4bEO2oj
Pedro T Ramirez Arthur_HC_Hsu Aarthi S Jayraj Andreina Fernandes IGCS ESGO European Network of Young Gynae Oncologists OncoAlert IJGC Fellows SoMe4GynOnc
Impact of alterations in tumor suppressor genes on survival outcomes in patients with de novo #mCSPC cancer receiving ADT with ARPI or docetaxel. Presentation by Arshit Narang AIIMS, New Delhi. #ASCO24 written coverage by Zach Klaassen Georgia Cancer Center > bit.ly/3V8pdKf ASCO
We're excited to announce another #MathsConf35 workshop! This one will be run by Adam Brown and Adam Mercer !
🧮 Teach (Maths) Like a Champion: A Playbook for Great Outcomes
🎟️ Book your ticket today:
completemaths.com/community/math…
The #OncoAlertTopTweet 🚨Day 4 #ASCO24 by
Matteo Lambertini, MD PhD
Real-world data on the impact of hormone receptor status on clinical outcomes of young women with gBRCAmut and early breast cancer
#OncoAlertAF
Dra. María Natalia Gandur Quiroga
Alizée Camps - - Maléa
Marta Perachino
Kathrin Heinrich
CONGRESS | #ASCO24 | marivi mateos Universidad de Salamanca shares a subgroup analysis from DREAMM-7 of BVd vs DVd in RRMM; concluding that BVd resulted in improved PFS and OS. BVd also resulted in improved outcomes in patients with poor prognostic features compared with DVd.
#mmsm #myeloma
Can we assess liver fibrosis and predict outcomes just using blood-based tests?
These two papers show that FIB-4 plus ELF accurately assess fibrosis and predict decompensation and mortality.
t.ly/T9-p8 t.ly/5nlgu #livertwitter
Neurology Podcast: Dr. Dan Ackerman and Dr. Silja Räty discuss the outcomes of patients with BAO treated with IVT only and compares IVT with endovascular thrombectomy. Listen now: bit.ly/3Vs1FBo Article: bit.ly/45gTtHC
#NeuroTwitter Dr. Daniel Ackerman MD FAAN
.Amin Nassar, MD explores treatment options for 1st line treatment of advanced pure large cell neuroendocrine carcinoma #ASCO24 revealing similar outcomes for chemo, IO & chemoIO, questioning the added benefit of chemoIO compared to chemo alone Anne Chiang OncoAlert
Avelumab first line maintenance for advanced #UrothelialCarcinoma : Long-term outcomes from the #JAVELIN Bladder 100 Trial in patients with histological subtypes. Presented by ylt Gustave Roussy > bit.ly/3VsbwXU Zach Klaassen #ASCO24